8-hydroxyquinoline-N-oxide copper(II)- and zinc(II)-phenanthroline and bipyridine coordination compounds: Design, synthesis, structures, and antitumor evaluation
作者:Ling-Qi Du、Chu-Jie Zeng、Dong-Yin Mo、Qi-Pin Qin、Ming-Xiong Tan、Hong Liang
DOI:10.1016/j.jinorgbio.2023.112443
日期:2024.2
[Zn(ONQ)(QD5)Cl] (NQ9), [Zn(ONQ)(QD2)Cl] (NQ10), [Zn(ONQ)(QD6)Cl] (NQ11), [Zn(ONQ)(QD7)Cl] (NQ12), and [Zn(ONQ)(QD3)Cl] (NQ13) supported on 8-hydroxyquinoline-N-oxide (H-ONQ), 2,2′-dipyridyl (QD1), 5,5′-dimethyl-2,2′-bipyridyl (QD2), 1,10-phenanthroline (QD3), 4,4′-dimethoxy-2,2′-bipyridyl (QD4), 4,4′-dimethyl-2,2′-bipyridyl (QD5), 5-chloro-1,10-phenanthroline (QD6), and bathophenanthroline (QD7), were first synthesized
十四种新型肿瘤靶向
铜(II)和
锌(II)配合物,[Cu(ONQ)(QD1)(NO 3 )]·CH 3 OH ( NQ3 )、[Cu(ONQ)(QD2)(NO 3 )] ( NQ2 ), [Cu(NQ)(QD2)Cl] ( NQ3 ), [Cu(ONQ)(QD1)Cl] ( NQ4 ), [Cu(ONQ)(QD3)](NO 3 ) ( NQ5 ), [ Cu(ONQ)(QD3)Cl] ( NQ6 )、[Zn(ONQ)(Q
D4)Cl] ( NQ7 )、[Zn(ONQ)(QD1)Cl] ( NQ8 )、[Zn(ONQ)(QD5)Cl ] ( NQ9 )、[Zn(ONQ)(QD2)Cl] ( NQ10 )、[Zn(ONQ)(QD6)Cl] ( NQ11 )、[Zn(ONQ)(QD7)Cl] ( NQ12 ) 和 [Zn (ONQ)(QD3)Cl] ( NQ13 )负载在
8-羟基喹啉-N-氧化物(H-ONQ)、2